GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AFT Pharmaceuticals Ltd (ASX:AFP) » Definitions » Price-to-Free-Cash-Flow

AFT Pharmaceuticals (ASX:AFP) Price-to-Free-Cash-Flow

: 78.57 (As of Today)
View and export this data going back to 2015. Start your Free Trial

As of today (2024-04-23), AFT Pharmaceuticals's share price is A$2.75. AFT Pharmaceuticals's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 was A$0.04. Hence, AFT Pharmaceuticals's Price-to-Free-Cash-Flow Ratio for today is 78.57.

The historical rank and industry rank for AFT Pharmaceuticals's Price-to-Free-Cash-Flow or its related term are showing as below:

ASX:AFP' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 39.15   Med: 54.95   Max: 165.22
Current: 80.29

During the past 8 years, AFT Pharmaceuticals's highest Price-to-Free-Cash-Flow Ratio was 165.22. The lowest was 39.15. And the median was 54.95.

ASX:AFP's Price-to-Free-Cash-Flow is ranked worse than
86.26% of 495 companies
in the Drug Manufacturers industry
Industry Median: 21.04 vs ASX:AFP: 80.29

AFT Pharmaceuticals's Free Cash Flow per Share for the six months ended in Sep. 2023 was A$0.02. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was A$0.04.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of AFT Pharmaceuticals was -29.60% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -35.30% per year.

During the past 8 years, AFT Pharmaceuticals's highest 3-Year average Free Cash Flow per Share Growth Rate was 64.30% per year. The lowest was -35.30% per year. And the median was 27.80% per year.


AFT Pharmaceuticals Price-to-Free-Cash-Flow Historical Data

The historical data trend for AFT Pharmaceuticals's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AFT Pharmaceuticals Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Free-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only - 42.35 - 44.02 150.43

AFT Pharmaceuticals Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Price-to-Free-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 44.02 - 150.43 -

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, AFT Pharmaceuticals's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AFT Pharmaceuticals Price-to-Free-Cash-Flow Distribution

For the Drug Manufacturers industry and Healthcare sector, AFT Pharmaceuticals's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where AFT Pharmaceuticals's Price-to-Free-Cash-Flow falls into.



AFT Pharmaceuticals Price-to-Free-Cash-Flow Calculation

AFT Pharmaceuticals's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=2.75/0.035
=78.57

AFT Pharmaceuticals's Share Price of today is A$2.75.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. AFT Pharmaceuticals's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 was A$0.04.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

AFT Pharmaceuticals  (ASX:AFP) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


AFT Pharmaceuticals Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of AFT Pharmaceuticals's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


AFT Pharmaceuticals (ASX:AFP) Business Description

Traded in Other Exchanges
Address
129 Hurstmere Road, Level 1, Takapuna, Auckland, NTL, NZL, 0622
AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Aqueous cream, Calci-tab, Maxigesic, Cromo-fresh, Crystaderm, Crytawash, Ellgy plus, Emulsifying ointment, and others. The group has four operating segments based on geographical location being, Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia which includes the sales and distribution activity relating to the Australian market.

AFT Pharmaceuticals (ASX:AFP) Headlines

No Headlines